Journal
VACCINE: X
Volume 13, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jvacx.2023.100278
Keywords
Epidemiology; Congenital varicella; Neonatal varicella infection; Vaccination; Australia
Categories
Ask authors/readers for more resources
A comparison and surveillance was conducted to assess the incidence and outcomes of congenital and neonatal varicella in Australia before and after vaccination. The study found a significant reduction in the incidence of CVS and NVI after vaccination. However, the infections still persist among mothers from countries without vaccination programs. Targeted screening and vaccination for young migrant, asylum seeker, and refugee women are proposed to prevent CVS and NVI.
To compare the incidence and outcomes of congenital and neonatal varicella in Australia in the pre-vaccination (1995-1997) and post-vaccination era (after 2005 to November 2020), active prospective national surveillance for congenital varicella syndrome (CVS) and neonatal varicella infection (NVI) was conducted through the Australian Paediatric Surveillance Unit (APSU). Compared with 1995-1997, there was a 91.5% reduction in the incidence of CVS and a 91.3% reduction in the incidence of NVI in 2009-2020. However, almost half of the mothers in 2009-2020 were born overseas and came from coun-tries without a vaccination program. Although there has been a substantial and sustained decrease in the reported incidence of CVS and NVI in Australia since 2006, congenital and neonatal varicella infections persist. Thus, there is an opportunity for targeted screening of varicella in young migrant, asylum seeker and refugee women at risk of varicella infection and prioritisation for vaccination to prevent CVS and NVI.(c) 2023 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available